Though the findings did not reach statistical significance, the results from a trial in CF patients showed a net reduction in P. aeruginosa bacterial density of 0.5 log CFU in AZM-treated patients at day 168 versus placebo [ 246 ].
← all excerpts
Sub-Inhibitory Antibiotic Exposure and Virulence in <i>Pseudomonas aeruginosa</i>.
1
—
—